Showing 681 - 700 results of 134,516 for search '(( a d decrease ) OR ( 5 ((((mg decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.76s Refine Results
  1. 681

    FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

    Published 2013
    “…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”
  2. 682
  3. 683
  4. 684
  5. 685

    The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

    Published 2014
    “…<p>(<b>A</b>) Genome-wide expression of 5′ splice sites, 3′ splice sites, and introns are increased relative to exons upon treatment of HeLa cells with isoginkgetin (30 µM, 18 hours), based on total RNA-Seq (dUTP method <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone.0089673-Parkhomchuk1" target="_blank">[18]</a>, Illumina). …”
  6. 686
  7. 687
  8. 688
  9. 689
  10. 690

    Overexpression of Pax6 decreases Olig2 protein levels. by Eun Sook Jang (217069)

    Published 2011
    “…</b> Each result represents a mean ± S.D. of three independent experiments. …”
  11. 691
  12. 692
  13. 693
  14. 694
  15. 695
  16. 696
  17. 697

    CXCL12 expression results in decreased proliferation of PDAC cells. by Ishan Roy (530438)

    Published 2014
    “…(C–D) Propidium Iodide cell cycle analysis revealed a decrease in percentage of cells in the G<sub>2</sub> phase in CXCL12-expressing cells compared to GFP controls. (*), (**), and (***) denote <i>P</i>≤0.05, <i>P</i>≤0.01, and <i>P</i>≤0.001 respectively in comparison to control cells (GFP). …”
  18. 698
  19. 699
  20. 700